Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using...

Area of Science:

• Pharmacogenomics
• Molecular Biology

Background:

• The solute carrier organic anion transporter family member B1 (SLCO1B1) gene encodes OATP1B1, crucial for drug transport.
• Three single nucleotide polymorphisms (SNPs) in SLCO1B1 are known to affect OATP1B1 function and drug pharmacokinetics.
• Altered pharmacokinetics are observed for OATP1B1 substrates like pravastatin and SN-38.

Purpose of the Study:

• To develop rapid and reliable screening assays for three specific SLCO1B1 SNPs (-11187G>A, 388A>G, 521T>C).
• To determine the allelic frequencies of these SLCO1B1 SNPs and associated haplotypes in a Caucasian population.
• To facilitate the assessment of the clinical significance of these genetic variants.

Main Methods:

• Development of three simplex Pyrosequencing assays for SLCO1B1 SNP detection.
• Screening of 250 DNA samples from healthy Caucasian volunteers.
• In silico haplotyping to identify SLCO1B1 haplotypes based on SNP data.

Main Results:

• Pyrosequencing assays accurately identified the three target SLCO1B1 SNPs, validated by conventional sequencing.
• Frequencies of variant alleles were: -11187A (0.09), 388G (0.47), and 521C (0.12).
• Allelic frequencies for key haplotypes were SLCO1B1*15B (0.09) and *17 (0.02).

Conclusions:

• Developed Pyrosequencing assays provide a quick and dependable method for identifying functionally relevant SLCO1B1 SNPs.
• These assays support the evaluation of SLCO1B1 variants' impact on OATP1B1 substrate pharmacokinetics.
• Facilitates understanding of genetic influences on drug response and personalized medicine.